⚠️ Consumer Products Updated July 2026

Kratom and Kava Drink Lawsuits: Ingredient Disclosure and Dependence Claims

Claims allege that drinks marketed as natural relaxation products contained kratom without adequate disclosure of its effects and dependence potential.

Category

Consumer Products

Coverage

2025-2026

Last Updated

July 2026

Content Type

Legal Analysis

What the Claims Concern

Litigation has concerned beverages sold in convenience stores and wellness outlets marketed as natural alternatives to alcohol, promoting relaxation and focus. The allegation is that they contained kratom, an ingredient with opioid-like activity, without adequate disclosure.

Kratom comes from a Southeast Asian tree, and its principal alkaloids act on opioid receptors. Users have reported dependence and withdrawal, which is the harm at the centre of these claims.

🚨

Kratom acts on opioid receptors

Despite being sold as a botanical wellness product, kratom principal compounds bind opioid receptors, and dependence and withdrawal are documented. Anyone considering stopping after sustained use should seek medical advice rather than stopping abruptly.

Claims proceed under state consumer protection statutes, alleging that describing a product as a natural relaxation aid while omitting that it contained kratom, and omitting dependence potential, misled reasonable consumers.

The regulatory position is genuinely unsettled. Kratom is not a federally controlled substance, but federal agencies have warned about it, and several states and municipalities have banned or restricted sale while others regulate it through age limits and labelling rules.

That patchwork means a product lawfully sold in one state may be prohibited in the next, and it also means labelling requirements differ substantially by jurisdiction.

What Consumers Should Know

Read ingredient panels on any product marketed as a relaxation or focus aid. Botanical names may be used that are unfamiliar, and kratom appears under several designations including mitragyna speciosa.

Products sold as supplements are not reviewed for safety or effectiveness before sale in the way medicines are, so the absence of a warning does not indicate the absence of a risk.

⚠️

Supplements are not pre-approved for safety

Dietary supplements do not undergo pre-market safety and efficacy review. Responsibility for substantiation rests with the manufacturer, and regulators generally act after problems emerge rather than before sale.

Free Legal Evaluation

Do You Qualify to File a Claim?

Our network of verified plaintiff attorneys offers free, no-obligation case evaluations. Contingency fee representation means you pay nothing unless you win.

botanic tonics lawsuit Kratom Supplements Disclosure

Kratom and Kava Drink Lawsuits: Ingredient Disclosure and Dependence Claims: Frequently Asked Questions

Answers to the most common questions about this case and your legal options.

What do these lawsuits allege?

That drinks marketed as natural relaxation aids contained kratom without adequate disclosure of its opioid-like activity and dependence potential.

What is kratom?

A plant from Southeast Asia whose principal alkaloids act on opioid receptors, associated with reported dependence and withdrawal after sustained use.

Is kratom legal?

It is not federally controlled, but several states and municipalities have banned or restricted it while others regulate age and labelling, creating a patchwork.

Are supplements checked before sale?

No. Dietary supplements are not subject to pre-market safety and efficacy review, so absence of a warning does not indicate absence of risk.

What should I do if I have been using it regularly?

Seek medical advice rather than stopping abruptly, since withdrawal effects have been reported after sustained use.

LawsuitWatch Legal Research Team

Consumer Products Litigation Desk

The LawsuitWatch Legal Research Team monitors federal court PACER filings, MDL docket activity, regulatory enforcement actions, and legal settlements to deliver accurate, timely coverage of litigation affecting American consumers. Content is reviewed for factual accuracy before publication and updated as cases develop. Last reviewed: July 2026.